サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1588566

フローサイトメトリーの世界市場：2024年～2031年

Global Flow Cytometry Market - 2024-2031

出版日
ページ情報
英文 184 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
フローサイトメトリーの世界市場：2024年～2031年
出版日: 2024年11月08日
発行: DataM Intelligence
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

世界のフローサイトメトリー市場は、2023年に47億6,000万米ドルに達し、2024～2031年の予測期間中にCAGR 7.1％で成長し、2031年には82億4,000万米ドルに達すると予測されています。

フローサイトメトリーは、液体培地中に浮遊する細胞や粒子の物理的・化学的特徴を同定・定量化する高度な手法です。この技術は、レーザービームを通過する個々の細胞を迅速に検査することを可能にし、そこで細胞は光を照射され、光散乱と蛍光特性に基づいて評価されます。

フローサイトメトリーは、蛍光標識を用いて、細胞や粒子の大きさ、粒度、特異的なタンパク質マーカーなどのさまざまな特性を識別し、測定するレーザー駆動技術です。この方法により、ヘルスケア専門家は血液、骨髄、その他の体液サンプルを分析することができます。様々なタイプの細胞を検出し、その特徴を明らかにすることで、がんや感染症などの病気の診断に特に有用です。

市場力学：

促進要因

慢性疾患の増加と技術の進歩

世界のフローサイトメトリー市場の需要は、複数の要因によって牽引されています。主な要因の1つは、慢性疾患の罹患率の上昇と技術の進歩です。がん、糖尿病、心血管障害などの慢性疾患の有病率の増加は、フローサイトメーターのような高度な診断ツールに対する需要を大きく促進しています。早期診断は、慢性疾患における患者の転帰を高めるために不可欠です。フローサイトメトリーは細胞の特性を迅速かつ正確に分析するため、医療従事者は異常の早期発見が可能となります。

さらに、フローサイトメトリー技術の継続的な技術進歩、特にハイスループットフローサイトメトリー（HTFC）とスペクトルフローサイトメトリーの出現は、データの分解能を大幅に向上させ、より複雑な解析を容易にしています。HTFCは、1秒間に数千の細胞を調べることを可能にし、これは広範な研究活動に不可欠です。例えば、HyperCytのようなシステムは、マルチウェルプレートからの迅速なサンプルローディングを可能にし、毎分最大40ウェルを処理します。この迅速なスループットは、大量のサンプルを迅速に分析することが重要な創薬やスクリーニングのプロセスにおいて不可欠です。

さらに、この市場の成長を後押しするような製品の上市や承認も、この業界の主要企業の間で進んでいます。例えば、2024年5月、Agilent Technologies Inc.はNovoCyte Opteon Spectral Flow Cytometerを発表し、フローサイトメトリーアクセシビリティの著しい進歩を示しました。この革新的なシステムは、基礎研究、創薬、治療開発を含む様々な分野におけるフローデータの取得、分析、報告のための新たな基準を確立するものです。

また、2024年1月、IDEX Health &Science社は、フローサイトメトリーアプリケーション用に特別に設計されたSemrockラインのNanopede光学フィルターを発売しました。Nanopedeフィルターは、高いトランスミッションを提供する一方で、スペクトル全体にわたって不要な光（光学濃度OD5）を効果的に遮断するように設計されています。これにより、フローサイトメトリー中に収集される蛍光シグナルが明瞭で正確なものとなります。

同様に、2023年11月、CD Bioparticlesは、フローサイトメトリー実験の校正と標準化のために特別に設計された様々なタイプのポリスチレン粒子を含む、新しいフローサイトメトリー粒子シリーズの発売を発表しました。

阻害要因

高い装置コスト、個人の認識不足などの要因が市場の妨げになると予想されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 慢性疾患の増加と技術の進歩
    • 抑制要因
      • 設備コストの高さ
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 製品タイプ別

  • 試薬・消耗品
    • 抗体
    • アッセイとキット
    • その他
  • 分析機器
    • セルアナライザー
    • セルソーター
  • ソフトウェア
  • アクセサリー
  • サービス

第7章 技術別

  • セルベース
  • ビーズベース

第8章 用途別

  • 研究
    • 創薬
    • 幹細胞研究
    • 免疫学研究
    • アポトーシス分析
    • 細胞選別と生存性評価
  • 臨床
    • がん検出
    • 臓器移植
    • 免疫不全症
    • 血液学
  • 産業

第9章 エンドユーザー別

  • 製薬・バイオテクノロジー企業
  • 学術・研究機関
  • 病院・臨床検査機関
  • 血液銀行
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • Becton, Dickinson and Company
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Danaher Corporation（Beckman Coulter）
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Miltenyi Biotec
  • Sysmex Corporation
  • bioMerieux
  • Cytek Biosciences
  • Apogee Flow Systems Ltd.

第13章 付録

目次
Product Code: BT781

Overview

The global flow cytometry market reached US$ 4.76 billion in 2023 and is expected to reach US$ 8.24 billion by 2031 growing with a CAGR of 7.1% during the forecast period 2024-2031.

Flow cytometry is an advanced method to identify and quantify the physical and chemical traits of cells or particles suspended in a liquid medium. This technique enables the swift examination of individual cells as they move past a laser beam, where they are illuminated and evaluated based on their light scattering and fluorescence characteristics.

Flow cytometry is a laser-driven technique that identifies and measures different characteristics of cells or particles, such as size, granularity, and specific protein markers using fluorescent labeling. This method allows healthcare professionals to analyze blood, bone marrow, and other bodily fluids samples. It is especially valuable for diagnosing diseases like cancer and infections by detecting and characterizing various cell types.

Market Dynamics: Drivers

Rising incidence of chronic diseases and technological advancements

The demand for the global flow cytometry market is driven by multiple factors. One of the primary factors is the rising incidence of chronic diseases and technological advancements. The increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders is significantly driving the demand for advanced diagnostic tools like flow cytometers. Early diagnosis is essential for enhancing patient outcomes in chronic diseases. Flow cytometry provides quick and accurate analysis of cellular characteristics, allowing healthcare professionals to detect abnormalities at earlier stages.

Furthermore, continuous technological advancements in flow cytometry technology, particularly the emergence of high-throughput flow cytometry (HTFC) and spectral flow cytometry, are greatly improving data resolution and facilitating more intricate analyses. HTFC enables the examination of thousands of cells per second, which is vital for extensive research efforts. For instance, systems like HyperCyt allow for swift sample loading from multi-well plates, processing up to 40 wells every minute. This rapid throughput is essential in drug discovery and screening processes, where analyzing large quantities of samples quickly is crucial.

In addition, key players in the industry product launches and approvals that would drive this market growth. For instance, in May 2024, Agilent Technologies Inc. unveiled the NovoCyte Opteon Spectral Flow Cytometer, marking a significant advancement in flow cytometry accessibility. This innovative system establishes a new benchmark for acquiring, analyzing, and reporting flow data across various fields, including basic research, drug discovery, and therapy development.

Also, in January 2024, IDEX Health & Science launched the Semrock line of Nanopede Optical Filters, specifically designed for flow cytometry applications. The Nanopede filters are engineered to provide high transmission rates while effectively blocking unwanted light (optical density OD5) across the spectrum. This ensures that the fluorescence signals collected during flow cytometry are clear and accurate.

Similarly, in November 2023, CD Bioparticles announced the launch of a new range of Flow Cytometry Particles, which includes various types of polystyrene particles specifically designed for calibration and standardization in flow cytometry experiments.

Restraints

Factors such as high equipment costs, and lack of awareness among individuals, are expected to hamper the market.

Segment Analysis

The global flow cytometry market is segmented based on product type, technology, application, end-user, and region.

The reagents and consumables segment accounted for approximately 43.9% of the global flow cytometry market share

The reagents and consumables segment is expected to hold the largest market share over the forecast period. The reagents and consumables segment is a crucial element of the flow cytometry market, significantly contributing to its growth and application across multiple domains. This segment includes a variety of essential products for performing flow cytometry assays, such as antibodies, assays, kits, and various other reagents.

Moreover, key players in the industry have innovative product launches & approvals and technological advancements that would drive this market growth. For instance, in August 2024, Bio-Rad Laboratories, Inc. announced the launch of annexin V conjugated to eight StarBright Dyes: SBUV400, SBUV795, SBV440, SBV515, SBV790, SBB675, SBB765, and SBY800. These new Annexin V StarBright conjugates facilitate the detection of early apoptotic cells through flow cytometry and provide researchers with a broader selection of fluorophore options. This expansion enhances the ability to incorporate apoptosis detection into multicolor immunophenotyping panels for both conventional and full-spectrum flow cytometry applications.

Also, in May 2023, Sysmex Corporation launched its Clinical Flow Cytometry System, which includes the Flow Cytometer XF-1600 and Sample Preparation System PS-10, along with antibody reagents and related products in Japan. The introduction of the XF-1600 is anticipated to greatly enhance workflow efficiency in clinical laboratories by minimizing manual tasks and promoting standardization. This development aligns with Sysmex's dedication to improving diagnostic capabilities and tackling medical challenges through innovative solutions.

Similarly, in March 2024, Beckman Coulter Life Sciences received 510(k) clearance from the Food and Drug Administration (FDA) to distribute its DxFLEX Clinical Flow Cytometer in the United States. This development brings the widely used benchtop IVD flow cytometry system to American laboratories while enhancing their testing capabilities. The DxFLEX system supports up to 13 colors, and additional detectors can be activated as laboratory needs change, eliminating the necessity for new hardware purchases.

Geographical Analysis

North America accounted for approximately 44.8% of the global flow cytometry market share

North America region is expected to hold the largest market share over the forecast period owing to the growing prevalence of chronic diseases, especially cancer and immunodeficiency disorders, which is a significant factor driving the flow cytometry market. The American Cancer Society indicated that around 1.9 million new cancer cases would be diagnosed in the U.S. in 2022, which would drive the need for effective diagnostic tools like flow cytometry. As healthcare professionals increasingly seek faster and more precise diagnostic methods, the importance of flow cytometry continues to rise.

Technological advancements in flow cytometry are significantly enhancing its capabilities, leading to better resolution and sensitivity in quantifying different cell types. Innovations like multi-parameter analysis enable thorough immunophenotyping, which is vital for diagnosing and tracking diseases such as leukemia and lymphoma. Additionally, the launch of new instruments and software solutions is further driving market growth.

Moreover, in this region, a major number of key player's presence, well-advanced healthcare infrastructure, and government initiatives & regulatory support, and investment in research and development would drive this market growth. For instance, in June 2023, in New Jersey, BD (Becton, Dickinson and Company) announced the global launch of a new automated instrument designed for preparing samples for clinical diagnostics using flow cytometry. This innovative system facilitates a complete "walkaway" workflow solution aimed at enhancing standardization and reproducibility in cellular diagnostics.

Also, in May 2023, in New Jersey BD (Becton, Dickinson and Company) announced the global launch of an innovative cell sorting instrument that incorporates two innovative technologies, significantly enhancing the capabilities of flow cytometry.

Market Segmentation

By Product Type

  • Reagents and Consumables
    • Antibodies
    • Assays and kits
    • Others
  • Instruments
    • Cell Analyzers
    • Cell Sorters
  • Software
  • Accessories
  • Services

By Technology

  • Cell-Based
  • Bead-Based

By Application

  • Research
    • Drug Discovery
    • Stem Cell Research
    • Immunology Studies
    • Apoptosis Analysis
    • Cell Sorting and Viability Assessments
  • Clinical
    • Cancer Detection
    • Organ Transplantation
    • Immunodeficiency Disorders
    • Hematology
  • Industrial

By End-User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Hospitals & Clinical Testing Laboratories
  • Blood Banks
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • The rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa

Competitive Landscape

The major global players in the flow cytometry market include Becton, Dickinson and Company, Danaher Corporation (Beckman Coulter), Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec, Sysmex Corporation, bioMerieux, Cytek Biosciences, and Apogee Flow Systems Ltd. among others.

Key Developments

  • In April 2024, Beckman Coulter Life Sciences introduced the QbD1200+ Total Organic Carbon (TOC) Analyzer. This new instrument simplifies and accelerates the analysis of pharmaceuticals and biopharmaceuticals, providing more robust data. It features streamlined validation processes and encrypted data reporting, ensuring compliance with 21 CFR Part 11 regulations and major global pharmacopeia standards.
  • In March 2024, Beckman Coulter Life Sciences announced the launch of the CytoFLEX nano Flow Cytometer, a specialized instrument designed for research purposes that significantly enhances the capabilities of flow cytometry. It can detect particles as small as 40 nm, marking a significant improvement over traditional flow cytometers, which typically have higher detection thresholds. This enhanced capability allows researchers to analyze smaller biological entities, such as extracellular vesicles (EVs), that are crucial for understanding various biological processes and diseases.
  • In January 2024, Cytek Biosciences, Inc. agreed with the Centre for Genomic Regulation (CRG) and Pompeu Fabra University (UPF). This collaboration aims to foster technological innovation and expedite discoveries for the scientific community.
  • In January 2023, METAFORA Biosystems announced the launch of METAflow, its digital flow cytometry platform, into the Research Use Only (RUO) market. METAflow features a sophisticated suite of unsupervised algorithms that streamline the analysis process, making it accessible to users of all skill levels, from novices to experts. This cloud-based software automates the multidimensional clustering of flow cytometry data, representing a significant improvement over existing solutions that may not be as effective, regardless of the user's data processing abilities.

Why Purchase the Report?

  • To visualize the global flow cytometry market segmentation based on product type, technology, application, end-user, and region and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of the flow cytometry market with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping is available in excel consisting of key products of all the major players.

The global flow cytometry market report would provide approximately 70 tables, 65 figures, and 184 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Technology
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Incidence of Chronic Diseases and Technological Advancements
    • 4.1.2. Restraints
      • 4.1.2.1. High Equipment Costs
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Reagents and Consumables*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Antibodies
    • 6.2.4. Assays and kits
    • 6.2.5. Others
  • 6.3. Instruments
    • 6.3.1. Cell Analyzers
    • 6.3.2. Cell Sorters
  • 6.4. Software
  • 6.5. Accessories
  • 6.6. Services

7. By Technology

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 7.1.2. Market Attractiveness Index, By Technology
  • 7.2. Cell-Based *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Bead-Based

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Research *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 8.2.3. Drug Discovery
    • 8.2.4. Stem Cell Research
    • 8.2.5. Immunology Studies
    • 8.2.6. Apoptosis Analysis
    • 8.2.7. Cell Sorting and Viability Assessments
  • 8.3. Clinical
    • 8.3.1. Cancer Detection
    • 8.3.2. Organ Transplantation
    • 8.3.3. Immunodeficiency Disorders
    • 8.3.4. Hematology
  • 8.4. Industrial

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Pharmaceutical & Biotechnology Companies*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Academic & Research Institutes
  • 9.4. Hospitals & Clinical Testing Laboratories
  • 9.5. Blood Banks
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Becton, Dickinson and Company *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Danaher Corporation (Beckman Coulter)
  • 12.3. Thermo Fisher Scientific Inc.
  • 12.4. Agilent Technologies, Inc.
  • 12.5. Bio-Rad Laboratories, Inc.
  • 12.6. Miltenyi Biotec
  • 12.7. Sysmex Corporation
  • 12.8. bioMerieux
  • 12.9. Cytek Biosciences
  • 12.10. Apogee Flow Systems Ltd.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us